The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ostroumova O.D.

Kafedra fakul'tetskoĭ terapii i professional'nykh bolezneĭ Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta im. A.I. Evdokimova, Moskva

Isaev R.I.

Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Pereverzev A.P.

Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Drug-induced insomnia in old and very old patients

Authors:

Ostroumova O.D., Isaev R.I., Pereverzev A.P.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8): 142‑152

DOI: 10.17116/jnevro2019119081142

Read: 2661 times

Download PDF (RU)
Contact the author
Table of contents

DRUG-INDUCED INSOMNIA IN OLD AND VERY OLD PATIENTS
DRUG-INDUCED INSOMNIA IN OLD AND VERY OLD PATIENTS

To cite this article:

Ostroumova OD, Isaev RI, Pereverzev AP. Drug-induced insomnia in old and very old patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):142‑152. (In Russ.)
https://doi.org/10.17116/jnevro2019119081142

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
The expe­rience of the narcological service medi­cal specialists in the prevention of substance use among adolescents and youth. Russian Journal of Preventive Medi­cine. 2025;(5):62-68
Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medi­cine. 2025;(5):111-116
Comparative analysis of preventive action of drinking sulfate mine­ral water on neurohormonal and immune regu­lation organs in radiation expo­sure to rats. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):45-51
Prevalence of postpartum depression in the Russian Fede­ration: a systematic review and meta-analysis. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):74-87
Possibilities for opti­mizing preventive and therapeutic dental care for the pediatric popu­lation of Chapayevsk using SWOT analysis. Russian Journal of Stomatology. 2025;(2):39-44
Rapi­dly progressive periodontitis. (A successful expe­rience of eighteen years of obse­rvation). Russian Journal of Stomatology. 2025;(2):61-67
Contribution of the Russian Academy of Sciences Academician R.G. Oganov to the deve­lopment of the dome­stic preventive cardiology. Russian Journal of Preventive Medi­cine. 2025;(6):7-10
Effe­ctiveness of hygienic training measures in the over the working age rural popu­lation of the Moscow region. Russian Journal of Preventive Medi­cine. 2025;(6):48-52
Risk factors for low back pain in healthcare professionals taking care for patients with redu­ced mobi­lity. Russian Journal of Preventive Medi­cine. 2025;(7):75-80
Abstract:

According to modern concepts, sleep disorders are considered as a common geriatric syndrome, which also emphasizes their polyfactorial genesis. One of the important factors inducing sleep disorders is the intake of various drugs, which becomes especially significant with the problems of polymorbidity and polypharmacy occurring in older age groups. The article provides a classification of drug-induced sleep disorders, which presents a wide range of conditions associated with a disturbance of the sleep-wake cycle. The authors present the frequency of insomnia associated with taking drugs from different pharmacological groups according to the literature, and consider mechanisms of insomnia development due to the effect on various receptors and neurotransmitter systems, as well as data on their effect on sleep structure. The article presents risk factors for drug-induced insomnia and discusses preventive measures and management of patients.

Keywords:

elderly people
drug-induced insomnia
risk factors
management tactics
prevention

Authors:

Ostroumova O.D.

Kafedra fakul'tetskoĭ terapii i professional'nykh bolezneĭ Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta im. A.I. Evdokimova, Moskva

Isaev R.I.

Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Pereverzev A.P.

Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia

Close metadata

References:

  1. Permpongkosol S. Iatrogenic disease in the elderly: risk factors, consequences, and prevention. Clin Interv Aging. 2011;6:77-82. https://doi.org/10.2147/CIA.S10252
  2. Dean GE, Weiss C, Morris JL, Chasens ER. Impaired Sleep: A Multifaceted Geriatric Syndrome. Nurs Clin North Am. 2017;52(3):387-404. https://doi.org/10.1016/j.cnur.2017.04.009
  3. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780-791. https://doi.org/10.1111/j.1532-5415.2007.01156.x
  4. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18(6):425-432. https://doi.org/10.1093/sleep/18.6.425
  5. Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117-129. https://doi.org/10.1055/s-2005-867080
  6. Cooke JR, Ancoli-Israel S. Sleep and its disorders in older adults. Psychiatr Clin North Am. 2006;29(4):1077-1093; abstract x-xi. Review. https://doi.org/10.1016/j.psc.2006.08.003
  7. McCall WV. Diagnosis and Management of Insomnia in Older People. Journal of the American Geriatrics Society. 2005;53(7):272-277. https://doi.org/10.1111/j.1532-5415.2005.53393.x
  8. Ancoli-Israel S, Cooke JR. Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J Am Geriatr Soc. 2005;53(7 suppl):264-271. https://doi.org/10.1111/j.1532-5415.2005.53392.x
  9. Becker NB, Jesus SN, João KADR, Viseu JN, Martins RIS. Depression and sleep quality in older adults: a meta-analysis. Psychol Health Med. 2016;22(8):889-895. https://doi.org/10.1080/13548506.2016.1274042
  10. Larsson C, Hansson EE, Sundquist K, Jakobsson U. Chronic pain in older adults: prevalence, incidence, and risk factors. Scand J Rheumatol. 2016;46(4):317-325. https://doi.org/10.1080/03009742.2016.1218543
  11. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Medicine. 2005;6:347-352. https://doi.org/10.1016/j.sleep.2004.12.005
  12. Isaev RI, Yakhno NN. Narushenie sna pri bolezni Altsgeymera. Nevrologicheskiy Zhurnal. 2017;22:5:228-336.
  13. Jain KK. Drug-induced sleep disorders. http://www.medlink.com/article/drug-induced_sleep_disorders
  14. Forsyth LL. Sleep disorders. In Tisdale JE,‎ Miller DA eds. Drug-induced diseases. Second edition. American Society of Health-System Pharmacists; Bethesda, Md. 2010;293-300.
  15. International Classification of Sleep Disorders. American Academy of Sleep Medicine. 3rd ed. Darien, Illinois. 2014.
  16. American Academy of Sleep Medicine, ICSD-2: The International Classification of Sleep Disorders. Diagnostic and Coding Manual, AASM, Westchester, Ill, USA, 2nd edition, 2005.
  17. Tisdale JE, Miller DA, eds. Drug-induced diseases. Third edition. American Society of Health-System Pharmacists; Bethesda, Md. 2018.
  18. Doghramji K, Jangro WC. Adverse Effects of Psychotropic Medications on Sleep. Sleep Med Clin. 2016;11(4):503-514. https://doi.org/10.1016/j.jsmc.2016.08.001
  19. Foral P, Knezevich J, Dewan N, Malesker M. Medication-induced sleep disturbances. The Consultant pharmacist: the journal of the American Society of Consultant Pharmacists. 2011. http://www.biomedsearch.com/nih/Medication-induced-sleep-disturbances/21628140.html https://doi.org/10.4140/tcp.n.2011.414
  20. Gastel AV. Drug-Induced Insomnia and Excessive Sleepiness. Sleep Med Clin. 2018;13(2):147-159. https://doi.org/10.1016/j.jsmc.2018.02.001
  21. Malangu N. Drugs Inducing Insomnia as an Adverse Effect, Can’t Sleep? Issues of Being an Insomniac. Intech. 2012. https://www.intechopen.com/books/can-t-sleep-issues-of-being-an-insomniac/drugs-inducing-insomnia-as-an-adverse-effect https://doi.org/10.5772/30921
  22. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, Singleton N, Meltzer M. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep. 2006;29(11):1391-1397. https://doi.org/10.1093/sleep/29.11.1391
  23. Levenson JC, Benca RM, Rumble ME. Sleep related cognitions in individuals with symptoms of insomnia and depression. J Clin Sleep Med. 2015;11(8):847-854. https://doi.org/10.5664/jcsm.4930
  24. Alberti S, Chiesa A, Andrisano C, Serretti A. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol. 2015;35(3):296-303. https://doi.org/10.1097/jcp.0000000000000329
  25. Wyatt RJ, Fram DH, Kupfer DJ, Snyder F. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients. Arch Gen Psychiatry. 1971;24(2):145-155.
  26. Kupfer DJ, Bowers MB Jr. REM sleep and central monoamine oxidase inhibition. Psychopharmacologia. 1972;27(3):183-190. https://doi.org/10.1007/bf00422798
  27. Monti JM. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry Suppl. 1989;(6):61-65. https://doi.org/10.1192/s000712500029750x
  28. Beasley CM Jr, Sayler ME, Weiss AM, Potvin JH. Fluoxetine: activating and sedating effects at multiple fixed doses. J Clin Psychopharmacol. 1992;12(5):328-333. https://doi.org/10.1097/00004714-199210000-00006
  29. Luthringer R, Toussaint M, Schaltenbrand N, Bailey P, Danjou PH, Hackett D, Guichoux JY, Macher JP. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull. 1996;32(4):637-646.
  30. Krystal AD, Goforth HW, Roth T. Effects of antipsychotic medications on sleep in schizophrenia. Int Clin Psychopharmacol. 2008;23(3):150-160. https://doi.org/10.1097/yic.0b013e3282f39703
  31. Üçok A, Saka MC, Bilici M. Effects of paliperidone extended release on functioning level and symptoms of patients with recent onset schizophrenia: an open-label, single-arm, flexible-dose, 12-months follow-up study. Nord J Psychiatry. 2015;69(6):426-432. https://doi.org/10.3109/08039488.2014.996252
  32. Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007;22(5):299-308. https://doi.org/10.1097/yic.0b013e3281c55f4f
  33. Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson’s disease. Exp Neurol. 2013;243:45-56. https://doi.org/10.1016/j.expneurol.2012.08.018
  34. Chahine LM, Amara AW, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson’s disease from 2005 to 2015. Sleep Med Rev. 2017;35:33-50. https://doi.org/10.1016/j.smrv.2016.08.001
  35. Schweitzer PK, Randazzo AC. Drugs that disturb sleep and wakefulness. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 6th edition. Philadelphia: Elsevier; 2017. https://doi.org/10.1016/b978-0-323-24288-2.00045-3
  36. Chang CK, Yang YHK, Lin SJ, Cheng CL, Lin LJ. Risk of insomnia attributable to β-blockers in elderly patients with newly diagnosed hypertension. Drug Metab Pharmacokinet. 2013;28(1):53-58. https://doi.org/10.2133/dmpk.dmpk-12-rg-004
  37. Nesbitt AD. Headache, drugs and sleep. Cephalalgia. 2014;34(10):756-766. https://doi.org/10.1177/0333102414542662
  38. Kosari S, Naunton M. Sleep disturbances and nightmares in a patient treated with prazosin. J Clin Sleep Med. 2016;12(4):631-632. https://doi.org/10.5664/jcsm.5708
  39. Samizo K, Kawabe E, Hinotsu S, Sato T, Kageyama S, Hamada C, Ohashi Y, Kubota K. Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan. Drug Saf. 2002;25(11):811-821. https://doi.org/10.2165/00002018-200225110-00005
  40. Chrousos GA, Kattah JC, Beck RW, Cleary PA. Side effects of glucocorticoid treatment. Experience of theoptic neuritis treatment trial. JAMA. 1993;269(16):2110-2112. https://doi.org/10.1001/jama.269.16.2110
  41. Korucu O, Demiryürek BE, Morkavuk G, Korucu AA. The effect of cholinesterase inhibitors on sleep in the patients with Alzheimer’s disease: an observational prospective study. Psychiatry and Clinical Psychopharmacology. 2018;28(1):14-18. https://doi.org/10.1080/24750573.2017.1368856
  42. Song HR, Woo YS, Wang HR, Jun TY, Bahk WM. Effect of the timing of acetylcholinesterase inhibitor ingestion on sleep. Int Clin Psychopharmacol. 2013;28(6):346-348. https://doi.org/10.1097/yic.0b013e328364f58d
  43. Naharci MI, Ozturk A, Yasar H, Cintosun U, Kocak N, Bozoglu E, Tasci I, Doruk H. Galantamine improves sleep quality in patients with dementia. Acta Neurol Belg. 2015;115(4):563-568. https://doi.org/10.1007/s13760-015-0453-9
  44. Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Disease & Associated Disorders. 2005;19(4):240-245. https://doi.org/10.1097/01.wad.0000189052.48688.36
  45. Jain U, Hechtman L, Weiss M, Ahmed TS, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry. 2007;68(2):268-277. https://doi.org/10.4088/jcp.v68n0213
  46. Poluektov MG, Buzunov RV, Averbukh VM Verbitskiy EV, Zakharov AV, Kelmanson IA, Korabelnikova EA, Litvin AYu, Madaeva Im, Palman Ad, Rusetskiy YuYu, Strygin KN, Yakupov EZ. Proekt klinicheskikh rekomendatsiy po diagnostike i lecheniyu khronicheskoy insomnia u vzroslykh. Consilium Medicum. Prilozhenie: nevrologiya i revmatologiya. 2016;2:41-51. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.